• About CCSB
  • |
  • News
  • |
  • Contact Us
  • |
  • Site Map
  •  
  •   中文版
CCSB's
  • ESG
  • Investor Relations
  • Events
  • Contract Research
  • Contract Manufacturing
  • API Products
CCBS NEWS

CCBS NEWS

News
Download
Contact Us
search

News

Home > News > News
news title
  • 2025/05/29The company accomplished Tacrolimus audit, a client from India
  • 2025/05/14The company accomplished Caspofungin/Trandolapril audit, a client from Greece
  • 2025/04/16The company accomplished Rapamycin audit, a client from Japan
  • 2025/04/09The company accomplished Mycophenolate Mofetil audit, a client from India
  • 2025/03/14The company accomplished Everolimus & Tacrolimus audit, a client from India
  • 2025/03/10The company accomplished Mycophenolate Mofetil audit, a client from India
  • 2025/02/20The company accomplished Tacolimus audit, a client from Germany
  • 2025/01/14The company accomplished Rapamycin audit, a client from Japan
  • 2025/01/10The company accomplished Everolimus audit, a client from US
  • 2024/11/28The company obtained US patent: PREPARATION METHOD OF TRILACICLIB
   1  2  3  4  5  6  7  8  9  10 Next  
© Chunghwa Chemical Synthesis & Biotech Co. Ltd. All right reserved.